関連する実験動画
Updated: Jul 16, 2026

06:21
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
アンドロゲン受容体遺伝子変異による曖昧な生殖器の薬理学的治療を目的とした
Lancet (London, England)
|October 30, 1999
まとめ
アンドロゲン受容体変異を有する46,XYの乳児は,曖昧な生殖器官を経験しました. 局所用ジヒドロテストステロン (DHT) ゲル治療は,男性の生殖器の発達を成功裏に回復させ,赤ん坊が染色体性に応じて育てられるようにしました.
科学分野:
- エンドクリノロジー エンドクリノロジー
- 遺伝学 遺伝学とは
- 発達生物学 発達生物学とは
背景:
- アンドロゲン受容体 (AR) 変異は性発達障害 (DSD) を引き起こす可能性があります.
- ARシグナリングを理解することは,46,XY個体におけるDSDの管理に不可欠です.
研究 の 目的:
- アンドロゲン受容体における新しいM807T変異を報告する.
- この変異を持つ46,XYの乳児の臨床表現と成功管理を記述する.
主な方法:
- アンドロゲン受容体の変異を特定するための遺伝子配列決定.
- 外部生殖器の臨床評価について.
- トピカルジヒドロテストステロン (DHT) ゲルによるホルモン療法.
主要な成果:
- アンドロゲン受容体遺伝子のM807T変異を特定しました.
- この変異は,テストステロンに対する細胞の反応を低下させたが,DHTはそうではなかった.
- 局所的なDHTゲル治療は,外部生殖器の完全な男性化をもたらしました.
結論:
- M807T変異は,特定の形態の部分的アンドロゲン無感性を引き起こします.
- 早期診断と標的型DHT療法により,46,XYの乳児の曖昧な生殖器を効果的に管理することができます.
- このケースは,男性性差別化におけるアンドロゲン受容体機能の重要な役割を強調しています.
関連する概念動画
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

